Best Agrolife Q1 turnaround: consolidated PAT doubles to Rs41 Cr as EBITDA margin jumps to 20%

Best Agrolife reported a sharp profitability recovery in Q1 FY27 (consolidated), with net profit of Rs40.65 Cr, up 104% from Rs19.92 Cr a year ago and a clean turnaround from the Rs37.24 Cr loss in Q4 FY26. Critically, the doubling was margin-led, not volume-led: revenue from operations grew just 3.9% YoY to Rs396.20 Cr, but gross margin expanded to 37% (from 29%) and EBITDA margin to 20% (from 12%), lifting net margin to ~10% from 5.2%. There are no exceptional items on either side, so the +104% is fully underlying — the driver is product mix (patented launches Fluzam, Cubax Power Extra plus Bestman, Fetagen, Warden Extra), price increases and cost management, exactly the profitability-recovery playbook management laid out on the Q4 FY26 concall. On that count the print meets — arguably beats — the company's own guidance of a "gradual" recovery starting Q1 FY27.

The basis matters here: standalone tells a weaker topline story (revenue Rs262.07 Cr, down ~16% YoY; PAT Rs31.42 Cr, +61%), so the consolidated growth is carried by subsidiaries — chiefly Best Crop Science — and the >100% consolidated PAT growth versus ~60% standalone is a material divergence readers will see elsewhere. Management flagged a genuine demand headwind: a delayed, uneven monsoon hit Kharif sowing, seed-treatment and crop-protection demand, so the revenue growth was modest by design and margins did the work. Inventory was cut ~6% YoY to Rs764 Cr, extending the working-capital discipline (FY26 inventory Rs651 Cr, opex cut 15%) that management had promised.

The stock went into the print at ₹15.19, down 5.4% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

No brokerage consensus exists for this small-cap, so there is no street bar to grade against; the earnings call is July 31. Two non-operating overhangs sit alongside the print: the ongoing Income-Tax search-and-seizure proceedings (demand orders and reassessment notices across the holding company and subsidiaries, impact not ascertainable, auditor emphasis-of-matter) and the Q1 forfeiture of Rs37.5 Cr on 23.4 lakh lapsed warrants. Neither affects the reported P&L, but both belong on the watch list going into the peak Kharif quarter, when management expects demand to gain momentum.